AbbVie Inc. (ETR:4AB)
159.20
-1.40 (-0.87%)
Jun 27, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $13.34B USD in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.36
Revenue / Employee
$1.04M
Employees
55,000
Market Cap
284.47B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
AbbVie News
- 2 days ago - Elahere Market Opportunities and Strategies to 2034: Abbvie Secures European Approval for Elahere in Platinum-Resistant Ovarian Cancer - GlobeNewsWire
- 2 days ago - My Dividend Stock Portfolio: New May Dividend Record - 100 Holdings With 15 Buys - Seeking Alpha
- 3 days ago - 2 Dividend Aristocrats Bargains To Buy And 'Never Let Go' - Seeking Alpha
- 4 days ago - 3 dividend stocks investors can look for stability as Iran attacks US base in Qatar - Invezz
- 7 days ago - J&J, AbbVie get EU endorsement for Imbruvica's expanded approval - Seeking Alpha
- 7 days ago - I'm Buying Dividend Giants At Huge Discounts - Seeking Alpha
- 7 days ago - AbbVie declares $1.64 dividend - Seeking Alpha
- 7 days ago - AbbVie Declares Quarterly Dividend - PRNewsWire